DUSTS: Dexamethasone for Ureteral Stent Symptoms
This study, called DUSTS, is looking at whether a higher dose of dexamethasone, a steroid, can help reduce pain and urinary symptoms after surgery for kidney stones. During this surgery, a small tube called a ureteral stent is placed. Researchers want to see if giving 20 mg of dexamethasone, compared to the usual 4 mg, improves your quality of life two days after surgery. You may be able to join if you are between 18 and 70 years old, are having a ureteroscopy (a procedure to remove kidney stones) with a stent placed, and can read English. The study is currently recruiting about 70 participants.
- Study design
- This interventional study will randomly assign participants to receive either 20 mg or 4 mg of dexamethasone. About 70 participants will be enrolled.
- What's involved
- You will receive dexamethasone during surgery, fill out questionnaires on day 1 and 2 after surgery, complete a medication diary for one week, and have a clinic visit on day 2. You will be in the study for 30 days.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your quality of life will be measured two days after surgery, and you will be in the study for a total of 30 days.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Dexamethasone for Ureteral STent Symptoms (DUSTS)
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Monica Morgan, MD · PRINCIPAL_INVESTIGATOR · The Methodist Hospital Research Institute
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Global Quality of Life Score of Ureteral Stent Symptom Questionnaire (USSQ)Day 2 after surgery
A 1 to 7 rating scale used to measure survey participants' feeling if they were advised to have another stent inserted, from 1 = delighted to 7 = terrible.